FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Go back to FDA Approves New Prostate Cancer Imaging Agent Gozellix®| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.62 +0.17 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.45 | 52 Week High | $2.18 | |||
| Open | $11.44 | 52 Week Low | $0.30 | |||
| Day High | $11.69 | P/E | N/A | |||
| Day Low | $11.35 | EPS | $-3.32 | |||
| Volume | 850,950 | |||||
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.62 +0.17 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.45 | 52 Week High | $2.18 | |||
| Open | $11.44 | 52 Week Low | $0.30 | |||
| Day High | $11.69 | P/E | N/A | |||
| Day Low | $11.35 | EPS | $-3.32 | |||
| Volume | 850,950 | |||||

